Akebia Therapeutics, Inc. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Akebia Therapeutics, Inc. (AKBA) is 1.40

According to Akebia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.40. This represents a change of -18.43% compared to the average of 1.72 of the last 4 quarters.

Akebia Therapeutics, Inc. (AKBA) Historical Current Ratio (quarterly & annually)

How has AKBA Current Ratio performed in the past?

The mean historical Current Ratio of Akebia Therapeutics, Inc. over the last ten years is 1.65. The current 1.40 Current Ratio has changed 8.38% with respect to the historical average. Over the past ten years (40 quarters), AKBA's Current Ratio was at its highest in in the June 2016 quarter at 9.20. The Current Ratio was at its lowest in in the December 2021 quarter at 1.04.

Akebia Therapeutics, Inc. (AKBA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Akebia Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Akebia Therapeutics, Inc. (AKBA) Average Current Ratio

How has AKBA Current Ratio performed in the past?

The current Current Ratio of Akebia Therapeutics, Inc. (AKBA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Akebia Therapeutics, Inc. (AKBA) Current Ratio vs. Peers

How is AKBA’s Current Ratio compared to its peers?

Akebia Therapeutics, Inc.’s Current Ratio is less than Corvus Pharmaceuticals, Inc. (19.81), less than Prothena Corporation plc (10.43), less than Olema Pharmaceuticals, Inc. (10.88), less than Gossamer Bio, Inc. (2.20), less than Rigel Pharmaceuticals, Inc. (2.62), less than KalVista Pharmaceuticals, Inc. (5.58), less than Ventyx Biosciences, Inc. (17.86), less than Compass Therapeutics, Inc. (19.04), less than 4D Molecular Therapeutics, Inc. (9.34), less than Zevra Therapeutics, Inc. (4.89),

Build a custom stock screener for Akebia Therapeutics, Inc. (AKBA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akebia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Akebia Therapeutics, Inc. (AKBA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Akebia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.